Auguste Patrick, Javerzat Sophie, Bikfalvi Andreas
Molecular Angiogenesis Laboratory (INSERM EMI 0113), University Bordeaux I, Avenue des Facultés, 33405, Talence, France.
Cell Tissue Res. 2003 Oct;314(1):157-66. doi: 10.1007/s00441-003-0750-0. Epub 2003 Jul 8.
Fibroblast growth factors (FGFs) are potent stimulators of angiogenesis in vitro and in vivo. However, the precise role of FGFs and vascular development in normal and pathological tissue has long remained ill defined. Recently, substantial progress has been made toward a better understanding of their role. Genetic studies in mice or in culture systems indicate a role for FGFs in vessel assembly and sprouting. FGFs also stimulate blood vessel branching and lymphangiogenesis. The molecular mechanisms by which FGFs mediate angiogenesis are also better understood. Finally, the FGF/FGF-receptor system has become a focus for the development of novel therapeutic strategies for the treatment of angiogenesis-related diseases such as tissue ischemia.
成纤维细胞生长因子(FGFs)在体外和体内都是血管生成的有效刺激剂。然而,FGFs和血管发育在正常和病理组织中的精确作用长期以来一直不清楚。最近,在更好地理解它们的作用方面取得了实质性进展。对小鼠或培养系统的基因研究表明FGFs在血管组装和出芽中起作用。FGFs还刺激血管分支和淋巴管生成。FGFs介导血管生成的分子机制也得到了更好的理解。最后,FGF/FGF受体系统已成为开发治疗组织缺血等血管生成相关疾病新治疗策略的焦点。